NCT03834571 2022-06-21
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women
AIDS Malignancy Consortium
Phase 2 Withdrawn
Clinical Trials
8 trialsNCT03220009 2018-10-03
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT00428194 2017-11-29
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Withdrawn
NCT00600210 2017-08-23
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Leo W. Jenkins Cancer Center
Phase 2 Withdrawn
NCT00452920 2016-12-15
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
University of Miami
Phase 1/2 Withdrawn
NCT02501278 2016-05-13
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT00137358 2013-01-24
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
University of Alabama at Birmingham
Phase 1 Withdrawn
NCT00118300 2011-07-08
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Case Comprehensive Cancer Center
Phase 1 Withdrawn